205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.91%
Negative revenue growth while MPWR stands at 4.24%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
6.12%
Gross profit growth above 1.5x MPWR's 3.62%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-72.73%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-72.73%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
372.73%
Positive net income growth while MPWR is negative. John Neff might see a big relative performance advantage.
200.00%
Positive EPS growth while MPWR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
200.00%
Positive diluted EPS growth while MPWR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.25%
Share count expansion well above MPWR's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.48%
Diluted share count expanding well above MPWR's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.25%
Dividend reduction while MPWR stands at 24.40%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
786.67%
OCF growth of 786.67% while MPWR is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
125.30%
FCF growth of 125.30% while MPWR is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
11.86%
10Y revenue/share CAGR under 50% of MPWR's 574.75%. Michael Burry would suspect a lasting competitive disadvantage.
-14.43%
Negative 5Y CAGR while MPWR stands at 233.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-35.92%
Negative 3Y CAGR while MPWR stands at 40.56%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
11.67%
OCF/share CAGR of 11.67% while MPWR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-24.52%
Negative 3Y OCF/share CAGR while MPWR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-54.44%
Negative 10Y net income/share CAGR while MPWR is at 1299.44%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-61.41%
Negative 5Y net income/share CAGR while MPWR is 314.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-82.09%
Negative 3Y CAGR while MPWR is 13.70%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
131.78%
Below 50% of MPWR's 274.92%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
60.37%
Below 50% of MPWR's 133.09%. Michael Burry suspects a serious short-term disadvantage in building book value.
87.55%
Below 50% of MPWR's 673.26%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
14.29%
Below 50% of MPWR's 181.26%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
37.39%
Below 50% of MPWR's 99.66%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-5.10%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-9.02%
Inventory is declining while MPWR stands at 7.88%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.16%
Negative asset growth while MPWR invests at 4.37%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.55%
We have a declining book value while MPWR shows 4.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.23%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-6.71%
Our R&D shrinks while MPWR invests at 4.38%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.55%
SG&A growth well above MPWR's 13.82%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.